{"id":"b-mph","rwe":[{"pmid":"41299253","year":"2025","title":"High colonization by multidrug-resistant and virulent Staphylococcus aureus genotypes among critically ill patients in the COVID-19 pandemic in a Brazilian hospital.","finding":"","journal":"BMC microbiology","studyType":"Clinical Study"},{"pmid":"39747570","year":"2025","title":"The prevalence of multidrug resistance in Staphylococcus hominis isolated from clinical materials.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"36439817","year":"2022","title":"Coexistence of bla (NDM-5) and tet(X4) in international high-risk Escherichia coli clone ST648 of human origin in China.","finding":"","journal":"Frontiers in microbiology","studyType":"Clinical Study"},{"pmid":"36358134","year":"2022","title":"Genomic Characterization of an Extensively Drug-Resistant Extra-Intestinal Pathogenic (ExPEC) Escherichia coli Clinical Isolate Co-Producing Two Carbapenemases and a 16S rRNA Methylase.","finding":"","journal":"Antibiotics (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"35984599","year":"2022","title":"Genomic characterization of Salmonella enterica serovar Choleraesuis from Brazil reveals a swine gallbladder isolate harboring colistin resistance gene mcr-1.1.","finding":"","journal":"Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"New York State Psychiatric Institute","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":["Ritalin LA"],"company":"New York State Psychiatric Institute","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=B-MPH","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:29:33.141313+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:29:39.570674+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=B-MPH","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:29:40.461939+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL173732/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:29:52.319969+00:00"}},"allNames":["b-mph"],"offLabel":[],"synonyms":[],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"The technical details of B-mph's mechanism of action are currently unknown, as there is limited information available on its pharmacological properties and target."},"commercial":{},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=b-mph","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=b-mph","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:16:32.555001","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:29:54.260515+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"b-mph","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07314333","phase":"PHASE1","title":"A Trial to Assess How Centanafadine Interacts With Stimulants in the Body","status":"RECRUITING","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2026-02-05","conditions":["ADHD"],"enrollment":42,"completionDate":"2026-04-03"},{"nctId":"NCT05185583","phase":"PHASE2","title":"Methylphenidate in Childhood Apraxia of Speech","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-03-14","conditions":["Childhood Apraxia of Speech"],"enrollment":18,"completionDate":"2025-10-27"},{"nctId":"NCT06893718","phase":"NA","title":"Treadmill Training With and Without Compression Stockings on Toe Walking and Balance in Children With Autism.","status":"RECRUITING","sponsor":"Riphah International University","startDate":"2025-03-15","conditions":["Autism Spectrum Disorder"],"enrollment":24,"completionDate":"2025-05-12"},{"nctId":"NCT05832489","phase":"PHASE3","title":"EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2024-02-26","conditions":["Adult ADHD","Adult-onset ADHD With Mood Disorder"],"enrollment":80,"completionDate":"2027-05"},{"nctId":"NCT03326245","phase":"PHASE1","title":"Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2018-01-29","conditions":["Normal Physiology"],"enrollment":25,"completionDate":"2024-02-08"},{"nctId":"NCT02167048","phase":"PHASE1,PHASE2","title":"Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of British Columbia","startDate":"2014-06","conditions":["Attention Deficit Hyperactivity Disorders"],"enrollment":52,"completionDate":"2024-12"},{"nctId":"NCT05115747","phase":"NA","title":"Effect of Alter-G Training on Glycemic Control and Quality of Life in Diabetic Neuropathy","status":"COMPLETED","sponsor":"Umm Al-Qura University","startDate":"2021-01-15","conditions":["Diabetic Polyneuropathy"],"enrollment":80,"completionDate":"2021-10-20"},{"nctId":"NCT04964427","phase":"NA","title":"The Effects of Methylphenidate and Non-invasive Brain Stimulation on Inhibitory Control in Children With ADHD","status":"COMPLETED","sponsor":"Bambino Gesù Hospital and Research Institute","startDate":"2021-02-08","conditions":["Attention Deficit Hyperactivity Disorder"],"enrollment":26,"completionDate":"2022-11-02"},{"nctId":"NCT01074294","phase":"PHASE2","title":"Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2010-03-16","conditions":["Attention Deficit Hyperactivity Disorder"],"enrollment":740,"completionDate":"2011-06-20"},{"nctId":"NCT05635318","phase":"NA","title":"Quantitative EEG Neurofeedback as an Add-on Therapy For Attention-deficit Hyperactivity Disorder (ADHD)","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-01-01","conditions":["ADHD"],"enrollment":102,"completionDate":"2024-01-01"},{"nctId":"NCT04586179","phase":"NA","title":"A Comparison Between Cardiovascular Exercise Modes Following Sport Related Concussion","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2020-09-27","conditions":["Concussion, Mild","Sport Injury"],"enrollment":6,"completionDate":"2021-06-03"},{"nctId":"NCT01907360","phase":"PHASE1,PHASE2","title":"Pharmacokinetics of HLD200 in Children and Adolescents With ADHD","status":"COMPLETED","sponsor":"Ironshore Pharmaceuticals and Development, Inc","startDate":"2013-08","conditions":["Attention-Deficit Hyperactivity Disorder"],"enrollment":29,"completionDate":"2013-10"},{"nctId":"NCT04636645","phase":"NA","title":"Effects of Lower Limb Positive Pressure on the Balance of Community-dwelling Older Adults","status":"UNKNOWN","sponsor":"Riphah International University","startDate":"2020-11-19","conditions":["Old Age","Fall"],"enrollment":90,"completionDate":"2021-12-30"},{"nctId":"NCT01232361","phase":"","title":"IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents","status":"COMPLETED","sponsor":"International Maternal Pediatric Adolescent AIDS Clinical Trials Group","startDate":"2010-10-08","conditions":["ADHD","HIV"],"enrollment":127,"completionDate":"2016-07"},{"nctId":"NCT04149717","phase":"NA","title":"The Effect of Energy Drink Ingredients on Cardiovascular Function in Men and Women 18-39 Years Old","status":"UNKNOWN","sponsor":"Duquesne University","startDate":"2020-01-01","conditions":["Cardiac Arrhythmia","Blood Pressure"],"enrollment":35,"completionDate":"2023-03"},{"nctId":"NCT03185065","phase":"PHASE3","title":"Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-10-04","conditions":["Fatigue in Multiple Sclerosis"],"enrollment":141,"completionDate":"2019-11-21"},{"nctId":"NCT00257725","phase":"PHASE4","title":"Long-Duration Stimulant Treatment Study of ADHD in Young Children","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2005-03","conditions":["Attention Deficit Disorder With Hyperactivity"],"enrollment":11,"completionDate":"2008-03"},{"nctId":"NCT01408901","phase":"NA","title":"Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2011-09","conditions":["Peripheral Arterial Disease"],"enrollment":210,"completionDate":"2017-08-15"},{"nctId":"NCT03769064","phase":"PHASE1","title":"Study for Naltrexone on the Abuse Potential of Methylphenidate","status":"COMPLETED","sponsor":"Avekshan LLC","startDate":"2018-03-27","conditions":["Naltrexone","Methylphenidate Abuse"],"enrollment":94,"completionDate":"2018-06-20"},{"nctId":"NCT00863499","phase":"PHASE4","title":"International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder","status":"UNKNOWN","sponsor":"BRC Operations Pty. Ltd.","startDate":"2009-10","conditions":["Attention Deficit/Hyperactivity Disorder"],"enrollment":1344,"completionDate":"2019-12"},{"nctId":"NCT00670293","phase":"","title":"Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2008-07","conditions":["Eating Disorders"],"enrollment":50,"completionDate":"2015-12"},{"nctId":"NCT00506285","phase":"PHASE3","title":"Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD","status":"COMPLETED","sponsor":"University of Utah","startDate":"2007-06","conditions":["Attention Deficit Hyperactivity Disorder"],"enrollment":92,"completionDate":"2009-04"},{"nctId":"NCT01731405","phase":"","title":"Consumer Understanding and Use of Medication Guides","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2012-11","conditions":["Revised Medication Guide Formats"],"enrollment":600,"completionDate":"2014-02"},{"nctId":"NCT00323947","phase":"PHASE4","title":"Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2003-05","conditions":["Attention Deficit Disorder With Hyperactivity","Epilepsy"],"enrollment":33,"completionDate":"2007-11"},{"nctId":"NCT01599975","phase":"PHASE3","title":"A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV","status":"UNKNOWN","sponsor":"University of California, Los Angeles","startDate":"2012-05","conditions":["HIV Dementia"],"enrollment":40,"completionDate":"2014-09"},{"nctId":"NCT00269776","phase":"PHASE3","title":"An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder","status":"COMPLETED","sponsor":"Alza Corporation, DE, USA","startDate":"1998-11","conditions":["Attention Deficit Hyperactivity Disorder"],"enrollment":0,"completionDate":"1999-01"},{"nctId":"NCT00634439","phase":"","title":"Safety Study of Atomoxetine and Cerebrovascular Outcomes","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2008-01","conditions":["Cerebrovascular Accident","Transient Ischemic Attack","ADHD"],"enrollment":72000,"completionDate":"2008-09"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"chemblId":"CHEMBL173732"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"New York State Psychiatric Institute","relationship":"Original Developer"}],"publicationCount":20,"therapeuticAreas":["Other"],"biosimilarFilings":[],"originalDeveloper":"New York State Psychiatric Institute","recentPublications":[{"date":"2025 Nov 26","pmid":"41299253","title":"High colonization by multidrug-resistant and virulent Staphylococcus aureus genotypes among critically ill patients in the COVID-19 pandemic in a Brazilian hospital.","journal":"BMC microbiology"},{"date":"2025 Jan 2","pmid":"39747570","title":"The prevalence of multidrug resistance in Staphylococcus hominis isolated from clinical materials.","journal":"Scientific reports"},{"date":"2022","pmid":"36439817","title":"Coexistence of bla (NDM-5) and tet(X4) in international high-risk Escherichia coli clone ST648 of human origin in China.","journal":"Frontiers in microbiology"},{"date":"2022 Oct 26","pmid":"36358134","title":"Genomic Characterization of an Extensively Drug-Resistant Extra-Intestinal Pathogenic (ExPEC) Escherichia coli Clinical Isolate Co-Producing Two Carbapenemases and a 16S rRNA Methylase.","journal":"Antibiotics (Basel, Switzerland)"},{"date":"2022 Dec","pmid":"35984599","title":"Genomic characterization of Salmonella enterica serovar Choleraesuis from Brazil reveals a swine gallbladder isolate harboring colistin resistance gene mcr-1.1.","journal":"Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"B-MPH","companyName":"New York State Psychiatric Institute","companyId":"new-york-state-psychiatric-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:29:54.260515+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}